Thursday, March 06, 2025 | 06:26 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Orchid gets tentative US FDA nod for memantine

Image

BS Reporter Mumbai

Orchid Chemicals & Pharmaceuticals has received a tentative approval from the US Food and Drug Administration (US FDA) for memantine tablets.

According to a release issued by Orchid to the BSE today, the company has received US FDA nod for its abbreviated New Drug Application Memantine Hydrochloride tablets in 5 mg and 10mg strengths.

The stock meanwhile has gained 2% at Rs 190. Around 656,835 shares have changed hands at the counter on the NSE.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 08 2010 | 10:48 AM IST

Explore News